Journal of Capital Medical University ›› 2008, Vol. 29 ›› Issue (4): 436-439.

• 专题报道 • Previous Articles     Next Articles

Glycogen Synthase Kinase 3 and Bipolar Mood Disorder

Li Xiaohong, Liu Min, Luo Xiaonian, Wang Gang   

  1. Beijing Anding Hospital, Capital Medical University
  • Received:2008-06-08 Revised:1900-01-01 Online:2008-08-24 Published:2008-08-24

Abstract: To understand the role of glycogen synthase kinase 3(GSK3) in drug treatment and development of bipolar affective disorder,we introdued the biological features and promotion in apoptosis of GSK3 first.Then,we also reviewed some works of GSK3 in therapeutic drugs and animal models with bipolar affective disorder.

Key words: glycogen synthase 3, bipolar affective disorder, transcription factor, lithium salt

CLC Number: